Also known as: Cannabis for RLS · Marijuana and Willis-Ekbom disease · THC for restless legs

Cannabis and Restless Legs Syndrome

What the evidence actually says about using cannabis for RLS — separating small case series from genuine clinical findings.

Sourced and fact-checked
8 cited sources
Published 3 months ago
How this page was made
↯ The honest take

RLS is one of the few conditions where cannabis has surprisingly consistent patient-reported benefit — but 'consistent' here means a handful of small surveys and one case series, not real trials. There are zero randomized controlled trials of cannabis for RLS as of 2024. If standard treatments (dopamine agonists, gabapentinoids, iron) aren't working or are causing augmentation, cannabis is a plausible thing to discuss with a sleep neurologist. It is not a first-line option, and the evidence is thinner than enthusiasts suggest.

Not medical advice

This article is not medical advice. RLS is often a symptom of an underlying issue — iron deficiency, kidney disease, pregnancy, or a medication side effect — that needs a proper workup. If you have restless legs symptoms, see a clinician before self-treating with cannabis or anything else. Cannabis can interact with sedatives, antidepressants, and dopaminergic drugs commonly used for RLS.

Plain-language summary

Restless legs syndrome (RLS) is a neurological condition where you get an uncomfortable, hard-to-describe urge to move your legs, usually in the evening or at night, relieved temporarily by movement. It wrecks sleep. Standard treatments include iron supplementation when ferritin is low, gabapentin/pregabalin, dopamine agonists (pramipexole, ropinirole, rotigotine), and in severe cases low-dose opioids [1].

A small number of patients report that cannabis — usually smoked or vaporized flower — relieves their symptoms, sometimes dramatically. The published evidence consists of one French case series of six patients [2], a few survey studies [3][4], and scattered case reports. There are no randomized controlled trials. So we can say cannabis might help some people with RLS, but we cannot say how often, for how long, at what dose, or in comparison to anything else.

What probably works (in RLS generally — not cannabis)

Before getting to cannabis, the things with actual strong evidence for RLS are:

If you have not had a ferritin level checked, that is the first conversation to have with your doctor.

What might work: cannabis evidence

The most-cited paper is Megelin and Ghorayeb (2017), a case series of six RLS patients who used cannabis Weak / limited [2]. All six reported total or near-total symptom relief. Five smoked it; one used CBD oil. This is six patients, no control group, no blinding, self-selected.

A 2020 Israeli survey by Ghorayeb of patients in an online RLS community found that of those who had tried cannabis, most reported improvement in symptoms and sleep Weak / limited [3]. This is survey data with strong selection bias — people who got no benefit are less likely to be in the cannabis discussion in the first place.

A 2023 review in Sleep Medicine Reviews concluded that evidence is limited to case reports and uncontrolled studies, and called for randomized trials Weak / limited [4].

What we can reasonably say: a subset of RLS patients get meaningful subjective relief from cannabis, particularly inhaled forms with rapid onset that can be timed to evening symptoms. Whether this is a direct effect on the underlying RLS pathology, a sleep-promoting effect, an anxiolytic effect, or placebo cannot be untangled from current data.

What doesn't work / weak evidence

What we don't know

Almost everything that matters for a clinical recommendation:

Comparison with standard treatments

| Treatment | Evidence quality | Onset | Main downside | |---|---|---|---| | Iron (if deficient) | Strong | Weeks | Slow; only works if ferritin is low | | Gabapentin enacarbil / pregabalin | Strong | Days | Sedation, weight gain, dizziness | | Dopamine agonists | Strong short-term | Days | Augmentation with long-term use; impulse-control disorders | | Low-dose opioids | Strong (refractory cases) | Hours | Dependence, regulatory barriers | | Cannabis | Weak (case series, surveys) | Minutes (inhaled) | Cognitive effects, dependence potential, no long-term data |

None of the head-to-head comparisons have been done. Patient anecdotes that cannabis works 'better than ropinirole' are interesting but not evidence in the formal sense.

Risks and practical considerations

If you and your clinician decide to try cannabis for RLS:

The honest summary: cannabis for RLS is a reasonable thing to discuss with a sleep specialist if standard treatments have failed or caused augmentation. It is not a first-line treatment, and anyone telling you the evidence is strong is overselling six patients.

Sources

  1. Peer-reviewed Silber MH, Buchfuhrer MJ, Earley CJ, et al. The Management of Restless Legs Syndrome: An Updated Algorithm. Mayo Clinic Proceedings. 2021;96(7):1921-1937.
  2. Peer-reviewed Megelin T, Ghorayeb I. Cannabis for restless legs syndrome: a report of six patients. Sleep Medicine. 2017;36:182-183.
  3. Peer-reviewed Ghorayeb I. More evidence of cannabis efficacy in restless legs syndrome. Sleep and Breathing. 2020;24(1):277-279.
  4. Peer-reviewed Samaha D, Kandiah T, Zimmerman D, Burns KD. Cannabis use in restless legs syndrome: a scoping review. Sleep Medicine Reviews. 2023.
  5. Peer-reviewed Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease. Sleep Medicine. 2018;41:27-44.
  6. Peer-reviewed Garcia-Borreguero D, Silber MH, Winkelman JW, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation. Sleep Medicine. 2016;21:1-11.
  7. Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. 2017 (reaffirmed).
  8. Peer-reviewed Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242.

How this page was made

Generation history

Jan 21, 2026
Fact-check pass — raised 2 flags
Jan 20, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.